v3.5.0.2
Development and Other Agreements - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Jul. 31, 2014
Feb. 29, 2012
Sep. 30, 2015
Sep. 30, 2016
Dec. 31, 2015
Aug. 10, 2015
Feb. 01, 2012
Helmsley Grant [Member] | Research and Development Grant [Member]                
Development Agreements [Line Items]                
Research and Development Arrangement, Contract to Perform for Others, Compensation Earned       $ 0        
Tandem Diabetes Care, Inc. [Member]                
Development Agreements [Line Items]                
Royalty per Product Sold (in Dollars per Item)         $ 100      
Marketing Funds per Product Sold (in Dollars per Item)         100      
Tandem Diabetes Care, Inc. [Member] | Maximum [Member]                
Development Agreements [Line Items]                
Third party contribution to off set expenses               $ 1,000,000
Tandem Diabetes Care, Inc. [Member] | Initial Payment [Member]                
Development Agreements [Line Items]                
One-time milestone payment, received     $ 1,000,000          
Regulatory Submission Milestone [Member] | Tandem Diabetes Care, Inc. [Member]                
Development Agreements [Line Items]                
Additional milestone payments   $ 1,000,000            
Regulatory Approval Milestone [Member] [Member] | Tandem Diabetes Care, Inc. [Member]                
Development Agreements [Line Items]                
Additional milestone payments $ 1,000,000              
Google Life Sciences LLC [Member] | Collaborative Arrangement [Member]                
Development Agreements [Line Items]                
Sales Revenue, Goods, Net         750,000,000      
Collaborative Arrangement, Commitment Amount, Royalty Eligible Sales Threshold Not Achieved             $ 0  
Google Life Sciences LLC [Member] | Collaborative Arrangement [Member] | Milestone Payments [Member]                
Development Agreements [Line Items]                
Development & Regulatory Milestone Payments             65,000,000  
Google Life Sciences LLC [Member] | Collaborative Arrangement [Member] | Initial Payment [Member]                
Development Agreements [Line Items]                
Upfront Fee             $ 35,000,000  
Shares, Issued       404,591        
Share Price             $ 90.29  
Research and Development Expense [Member] | Google Life Sciences LLC [Member] | Collaborative Arrangement [Member] | Initial Payment [Member]                
Development Agreements [Line Items]                
R&D expense through issuance of common stock         $ 36,500,000 $ 36,500,000